Market Estimation Report of implantable cardiac pacemaker market size in China （2023）

01 .Product brief introduction 

1. Product classification

According to “2017 Medical Device Classification Catalogue” of NMPA, implantable pacemakers belong to the 12th category of active implantable devices and the management category is Ⅲ. 

 On the track, implantable cardiac pacemakers belong to medical consumables – high value consumables -C02 vascular interventional therapy materials – heart rhythm management equipment. 

 2.Application field

 Pacemaker implantation is the most important interventional therapy for arrhythmias. According to the data from the National Cardiovascular Disease Quality Control Information Platform, the main indications of pacemaker implantation surgery include sick sinus syndrome (55.3%) and conduction block (41.5%), and the proportion has remained stable in recent years. 

 02.Development driver

 1.Policy Factor 

 In recent years, the state has issued relevant policies and regulations for many times, listed transplant interventional devices as a key development field, vigorously promoted the development of cardiovascular interventional devices, encouraged domestic innovation, and tried to break the import monopoly. At the same time, the country has successively carried out the centralized collection of medical high-value consumables, and the dual-chamber pacemaker collection was first carried out in Jiangsu Province. Since then, Yunnan, Qinghai, Anhui, Shandong, Fujian and other provinces have also successively carried out the pacemaker collection. 

2.Socioeconomic factors 

China is about to age, and the incidence of cardiovascular and cerebrovascular diseases, orthopedic diseases and other diseases that the elderly are prone to will increase. According to the National Bureau of Statistics, cardiovascular and cerebrovascular diseases have become the top cause of urban population in China. The number of patients with arrhythmia has exceeded 10 million, and there will be an increase of 500,000 to 600,000 patients every year, and cardiac pacemaker is an effective way to treat chronic cardiac arrhythmia. China’s cardiac pacemaker market mainly presents the characteristics of high morbidity, wide patient population, stable market growth, low penetration rate and foreign monopoly, so there is a great demand for implantable medical devices in the medical market. 

At the same time, with the expansion of domestic replacement and collection scale, the price of implantable cardiac pacemakers will no longer remain high. Lepu Medical and Chuangling Heart, the non-compatible MRI cardiac pacemakers selected in Shaanxi Province in 2021, have lowered their average price to about 16,000 yuan. Along with the progress of patients’ medical understanding, the improvement of pacemaker penetration rate and the improvement of medical insurance reimbursement ratio, users’ acceptance of pacemakers will continue to improve. 

 03 Market Scale 

 1. Calculation logic

 Determining the scope of application: By analyzing the scope of application and indications of implantable cardiac pacemakers, determine the corresponding diseases and treatment means. 

 Determine the scope of application: By analyzing the scope of application and indications of implantable cardiac pacemakers, determine the corresponding diseases and treatment means. 

 Determining the product price: Determine the price of domestic and imported pacemaker products through the MDCLOUD Database of Joinchain, and calculate the average price by deducting the market share of domestic and imported products in the future. 

 Market size Measurement: Based on operation volume and product price, the market size of implantable cardiac pacemakers was calculated. 

 2.Data basis 

 （1） Online purchase data 

The data range is the network hanging and purchase price of various types of sealers from 2019 to 2021 

 (2) Authoritative report 

It is mainly reported procedure volume data from authoritative bodies such as the National Cardiovascular Centre and the Healthcare commission statistics. 

 3. Market size forecasting

By calculating the market size of the implant cardiac pacemaker from 2019 to 2021, based on the operation volume, the proportion of domestic products, and the average product price, and by calculating the compound growth rate calculation, the market size of the implant cardiac pacemaker in China is forecast to reach 6.948 billion yuan in 2025. 

 Figure 1. China Implantable Cardiac Pacemaker Market Size, 2019 to 2025E 

 Data Source：MDCLOUD 

 04.Market pattern 

 According to calculation, in 2021, domestic product implantation market share of implanted pacemaker in our country was 6.46%, the amount of implanted pacemaker increased by nearly 2 percentage points compared with last year. Therefore, there is a huge market space for domestic product replacement import. 

 Figure 2.   domestic implantable cardiac pacemaker market share in China in  2021 

Data Source：MDCLOUD 

 China is encouraging China end uses for more domestic products in latest years. Thus, more and more overseas manufacturers are planning localization in China. BradyKnows localization team has extensive experiences in facility establishment, audit, supplier evaluation, manufacturing, registration, and marketing in China. Pls feel free to let us know any questions on China entry via info@bradyknowsmedical.com 

Source|：Joinchain Medical Device 

Translated & edited ： Bradyknows